Logo image of AMRC

AMERESCO INC-CL A (AMRC) Stock Fundamental Analysis

NYSE:AMRC - New York Stock Exchange, Inc. - US02361E1082 - Common Stock - Currency: USD

10.75  +0.69 (+6.86%)

After market: 10.75 0 (0%)

Fundamental Rating

3

Overall AMRC gets a fundamental rating of 3 out of 10. We evaluated AMRC against 51 industry peers in the Construction & Engineering industry. AMRC may be in some trouble as it scores bad on both profitability and health. AMRC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AMRC had positive earnings in the past year.
In the past year AMRC had a positive cash flow from operations.
AMRC had positive earnings in each of the past 5 years.
In the past 5 years AMRC reported 4 times negative operating cash flow.
AMRC Yearly Net Income VS EBIT VS OCF VS FCFAMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.36%, AMRC is in line with its industry, outperforming 45.10% of the companies in the same industry.
AMRC has a Return On Equity of 5.59%. This is comparable to the rest of the industry: AMRC outperforms 54.90% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.99%, AMRC is doing worse than 62.75% of the companies in the same industry.
AMRC had an Average Return On Invested Capital over the past 3 years of 3.15%. This is significantly below the industry average of 12.16%.
Industry RankSector Rank
ROA 1.36%
ROE 5.59%
ROIC 1.99%
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
AMRC Yearly ROA, ROE, ROICAMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

AMRC has a Profit Margin of 3.20%. This is in the better half of the industry: AMRC outperforms 62.75% of its industry peers.
AMRC's Profit Margin has declined in the last couple of years.
AMRC has a Operating Margin (4.65%) which is comparable to the rest of the industry.
AMRC's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 14.47%, AMRC is in line with its industry, outperforming 49.02% of the companies in the same industry.
AMRC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.65%
PM (TTM) 3.2%
GM 14.47%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
AMRC Yearly Profit, Operating, Gross MarginsAMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMRC is destroying value.
AMRC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMRC has more shares outstanding
Compared to 1 year ago, AMRC has an improved debt to assets ratio.
AMRC Yearly Shares OutstandingAMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMRC Yearly Total Debt VS Total AssetsAMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

AMRC has an Altman-Z score of 0.93. This is a bad value and indicates that AMRC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.93, AMRC is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
AMRC has a Debt/Equity ratio of 1.46. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.46, AMRC is not doing good in the industry: 68.63% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Altman-Z 0.93
ROIC/WACC0.24
WACC8.32%
AMRC Yearly LT Debt VS Equity VS FCFAMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

AMRC has a Current Ratio of 1.46. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
AMRC has a better Current ratio (1.46) than 66.67% of its industry peers.
AMRC has a Quick Ratio of 1.45. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
AMRC has a Quick ratio of 1.45. This is in the better half of the industry: AMRC outperforms 74.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.45
AMRC Yearly Current Assets VS Current LiabilitesAMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The earnings per share for AMRC have decreased strongly by -19.69% in the last year.
Measured over the past 5 years, AMRC shows a small growth in Earnings Per Share. The EPS has been growing by 3.47% on average per year.
Looking at the last year, AMRC shows a very strong growth in Revenue. The Revenue has grown by 28.76%.
The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)-19.69%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%1.45%
Revenue 1Y (TTM)28.76%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%20.69%

3.2 Future

AMRC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.22% yearly.
AMRC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.64% yearly.
EPS Next Y-23.67%
EPS Next 2Y13.63%
EPS Next 3Y18.52%
EPS Next 5Y16.22%
Revenue Next Year6.69%
Revenue Next 2Y8.86%
Revenue Next 3Y9.51%
Revenue Next 5Y8.64%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMRC Yearly Revenue VS EstimatesAMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AMRC Yearly EPS VS EstimatesAMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.54, which indicates a very decent valuation of AMRC.
Based on the Price/Earnings ratio, AMRC is valued cheaper than 98.04% of the companies in the same industry.
AMRC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
With a Price/Forward Earnings ratio of 13.81, AMRC is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMRC indicates a rather cheap valuation: AMRC is cheaper than 88.24% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, AMRC is valued a bit cheaper.
Industry RankSector Rank
PE 10.54
Fwd PE 13.81
AMRC Price Earnings VS Forward Price EarningsAMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMRC indicates a somewhat cheap valuation: AMRC is cheaper than 62.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.97
AMRC Per share dataAMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

AMRC's earnings are expected to grow with 18.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)3.04
EPS Next 2Y13.63%
EPS Next 3Y18.52%

0

5. Dividend

5.1 Amount

No dividends for AMRC!.
Industry RankSector Rank
Dividend Yield N/A

AMERESCO INC-CL A

NYSE:AMRC (4/25/2025, 8:04:00 PM)

After market: 10.75 0 (0%)

10.75

+0.69 (+6.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners97.43%
Inst Owner Change-2.19%
Ins Owners7.23%
Ins Owner Change9.98%
Market Cap564.80M
Analysts76.84
Price Target23.97 (122.98%)
Short Float %9.23%
Short Ratio3.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.02%
Min EPS beat(2)-31.77%
Max EPS beat(2)-8.27%
EPS beat(4)1
Avg EPS beat(4)-22.14%
Min EPS beat(4)-66.19%
Max EPS beat(4)17.68%
EPS beat(8)2
Avg EPS beat(8)-14.29%
EPS beat(12)5
Avg EPS beat(12)-4.6%
EPS beat(16)9
Avg EPS beat(16)9.35%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)0.97%
Revenue beat(4)3
Avg Revenue beat(4)7.21%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)14.53%
Revenue beat(8)6
Avg Revenue beat(8)5.9%
Revenue beat(12)9
Avg Revenue beat(12)4.89%
Revenue beat(16)11
Avg Revenue beat(16)4.46%
PT rev (1m)-24.92%
PT rev (3m)-37.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-307.55%
EPS NY rev (1m)-55.77%
EPS NY rev (3m)-54.2%
Revenue NQ rev (1m)-3.4%
Revenue NQ rev (3m)-17.32%
Revenue NY rev (1m)-1.03%
Revenue NY rev (3m)-4.16%
Valuation
Industry RankSector Rank
PE 10.54
Fwd PE 13.81
P/S 0.32
P/FCF N/A
P/OCF 4.8
P/B 0.56
P/tB 0.6
EV/EBITDA 11.97
EPS(TTM)1.02
EY9.49%
EPS(NY)0.78
Fwd EY7.24%
FCF(TTM)-6.19
FCFYN/A
OCF(TTM)2.24
OCFY20.82%
SpS33.69
BVpS19.28
TBVpS17.86
PEG (NY)N/A
PEG (5Y)3.04
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 5.59%
ROCE 2.52%
ROIC 1.99%
ROICexc 2.06%
ROICexgc 2.11%
OM 4.65%
PM (TTM) 3.2%
GM 14.47%
FCFM N/A
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
ROICexc(3y)3.29%
ROICexc(5y)3.76%
ROICexgc(3y)3.41%
ROICexgc(5y)3.91%
ROCE(3y)3.99%
ROCE(5y)4.56%
ROICexcg growth 3Y-23.67%
ROICexcg growth 5Y-13.36%
ROICexc growth 3Y-23.08%
ROICexc growth 5Y-12.71%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Debt/EBITDA 8.65
Cap/Depr 496.15%
Cap/Sales 25.01%
Interest Coverage 0.75
Cash Conversion 68.55%
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.45
Altman-Z 0.93
F-Score6
WACC8.32%
ROIC/WACC0.24
Cap/Depr(3y)645.79%
Cap/Depr(5y)553.31%
Cap/Sales(3y)27.71%
Cap/Sales(5y)23.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.69%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%1.45%
EPS Next Y-23.67%
EPS Next 2Y13.63%
EPS Next 3Y18.52%
EPS Next 5Y16.22%
Revenue 1Y (TTM)28.76%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%20.69%
Revenue Next Year6.69%
Revenue Next 2Y8.86%
Revenue Next 3Y9.51%
Revenue Next 5Y8.64%
EBIT growth 1Y-2.23%
EBIT growth 3Y-5.42%
EBIT growth 5Y9.79%
EBIT Next Year89.6%
EBIT Next 3Y37.7%
EBIT Next 5Y27.29%
FCF growth 1Y47.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y268.02%
OCF growth 3YN/A
OCF growth 5YN/A